Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CAMP
CAMP
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CAMP News
Major Wall Street Rating Changes Overview
4d ago
CNBC
Camp4 Therapeutics Q1 Earnings Report Analysis
May 08 2026
seekingalpha
CAMP4 Therapeutics Reports Q1 2026 Financial Results and Business Highlights
May 08 2026
NASDAQ.COM
Camp4 Therapeutics Reports FY Earnings Miss with Strong Revenue Growth
Mar 05 2026
seekingalpha
CAMP4 Therapeutics Grants 8,000 Stock Options at $5.78 to New Employee
Jan 16 2026
Globenewswire
CAMP4 Therapeutics to Present Corporate Update at J.P. Morgan Healthcare Conference
Jan 06 2026
Globenewswire
Canadian GoldCamps Corp. Raises $1M and Announces Management Changes
Dec 19 2025
Globenewswire
Analyst: GSK Agreement Confirms the Value of CAMP4's Drug Discovery Platform
Dec 19 2025
Benzinga
CAMP4 Therapeutics Prices 5M Shares at $6 Each, Raising $30M
Dec 18 2025
Globenewswire
CAMP4 Partners with GSK, Secures $17.5 Million Upfront Payment
Dec 18 2025
Globenewswire
CAMP4 Partners with GSK, Secures $17.5M Upfront for ASO Development
Dec 18 2025
Newsfilter
CAMP4 Therapeutics Collaborates with GSK on ASO Drug Development
Dec 18 2025
NASDAQ.COM
CalAmp Earns Caterpillar Supplier Excellence Certification for Second Consecutive Year
Dec 17 2025
Globenewswire
Camposol Completes 6% Notes Tender Offer, Accepts $205 Million
Dec 17 2025
Globenewswire
CAMP4 Grants 92,000 Stock Options to New Employees
Dec 12 2025
Globenewswire
Camposol Appoints Julio Alcalde as New CFO to Enhance Financial Structure
Dec 11 2025
Globenewswire
Show More News
